Urine free light chains in SLE: clonal markers of B-cell activity and potential link to in vivo secreted Ig.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 10821464)

Published in J Clin Immunol on March 01, 2000

Authors

J E Hopper1, J Golbus, C Meyer, G A Ferrer

Author Affiliations

1: Department of Medicine, University of Illinois, Chicago 60612, USA.

Articles cited by this

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum (1992) 14.73

NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol (1993) 7.42

The use of the avidin-biotin complex as a tool in molecular biology. Methods Biochem Anal (1980) 6.48

Metabolism of immunoglobulins. Prog Allergy (1969) 5.74

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med (1984) 5.35

Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med (1984) 5.21

The role of the kappa enhancer and its binding factor NF-kappa B in the developmental regulation of kappa gene transcription. Cell (1987) 3.72

Human immunoglobulin kappa light-chain genes are deleted or rearranged in lambda-producing B cells. Nature (1981) 3.64

Occurrence of surface IgM, IgD, and free light chains of human lymphocytes. J Exp Med (1974) 2.93

Pneumococcal pneumonia: capsular polysaccharide antigenemia and antibody responses. Ann Intern Med (1976) 2.41

METABOLISM OF BENCE JONES PROTEINS. J Clin Invest (1964) 2.29

Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE. Arthritis Rheum (1977) 2.03

Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine (Baltimore) (1981) 1.83

Alpha-1-microglobulin: an indicator protein for renal tubular function. J Clin Pathol (1983) 1.80

The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia. J Clin Invest (1972) 1.70

Extracellular idiotypic immunoglobulin arising from human leukemic B lymphocytes. J Exp Med (1980) 1.57

Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosus. Am J Med (1980) 1.53

Mitogen activation of human chronic lymphatic leukemia cells. I. Synthesis and secretion of immunoglobulin. J Immunol (1977) 1.52

Solid-phase radioimmunoassay for immunoglobulin G Staphylococcus aureus antibody in serious staphylococcal infection. Ann Intern Med (1978) 1.51

Intrathecal synthesis of free immunoglobulin light chains and IgM in initial multiple sclerosis. Acta Neurol Scand (1991) 1.46

A novel enhancer in the immunoglobulin lambda locus is duplicated and functionally independent of NF kappa B. Genes Dev (1990) 1.43

Immunoglobulin synthesis by neoplastic B lymphocytes: free light chain synthesis as a marker of B cell differentiation. J Immunol (1980) 1.35

Tubular and interstitial renal disease due to immunologic mechanisms. Kidney Int (1975) 1.34

Constancy of urinary creatinine excretion. J Lab Clin Med (1958) 1.29

Polyclonally triggered B cells in the peripheral blood and bone marrow of normal individuals and in patients with systemic lupus erythematosus and primary Sjögren's syndrome. Arthritis Rheum (1981) 1.21

Endogenous retroviruses: potential etiologic agents in autoimmunity. FASEB J (1992) 1.17

A DIRECT IMMUNOLOGIC ASSAY OF HUMAN SERA FOR BENCE JONES PROTEINS (L-CHAINS). J Lab Clin Med (1965) 1.11

Evidence for transient requirement of the IgH enhancer. Nucleic Acids Res (1985) 1.10

Urinary albumin excretion in healthy adult subjects: reference values and some factors affecting their interpretation. Clin Chim Acta (1988) 1.06

NIH conference. Systemic lupus erythematosus. Ann Intern Med (1991) 1.06

Free light chains in the cerebrospinal fluid: an indicator of recent immunological stimulation. J Neurol Neurosurg Psychiatry (1985) 1.02

Pathogenesis of systemic lupus erythematosus. Rheum Dis Clin North Am (1988) 1.02

Increase of L-chain proteins in the sera of patients with systemic lupus erythematosus and the synovial fluids of patients with peripheral rheumatoid arthritis. Arthritis Rheum (1966) 1.01

Free light chains of immunoglobulins in serum from patients with rheumatoid arthritis, sarcoidosis, chronic infections and pulmonary cancer. Acta Med Scand (1981) 1.01

Contributions of heavy and light chains of rabbit immunoglobulin G to antibody activity. I. Binding studies on isolated heavy and light chains. Biochemistry (1972) 1.01

Pathologic changes in the renal tubule in systemic lupus erythematosus. Hum Pathol (1982) 1.00

Interstitial immune complex nephritis in patients with systemic lupus erythematosus. Kidney Int (1975) 0.98

Free immunoglobulin light chain synthesis by neoplastic cells in leukaemic reticuloendotheliosis. Clin Exp Immunol (1978) 0.96

Aberrant immunoglobulin synthesis in light chain amyloidosis. Free light chain and light chain fragment production by human bone marrow cells in short-term tissue culture. J Clin Invest (1986) 0.96

Bound and free light chains in subacute sclerosing panencephalitis and multiple sclerosis serum and cerebrospinal fluid. Z Klin Chem Klin Biochem (1975) 0.91

Free immunoglobulin light chain synthesis by human foetal liver and cord blood lymphocytes. Immunology (1981) 0.91

Mitogen-stimulated immunoglobulin production by chronic lymphocytic leukaemic lymphocytes. Clin Exp Immunol (1982) 0.91

Clinical relapse in systemic lupus erythematosus: correlation with antecedent elevation of urinary free light-chain immunoglobulin. J Clin Immunol (1989) 0.89

Ig light chains are secreted predominantly as monomers. J Immunol (1996) 0.88

Multiple sclerosis: free light chains in cerebrospinal fluid. Neurology (1985) 0.88

Increased antiretroviral antibody reactivity in sera from a defined population of patients with systemic lupus erythematosus. Correlation with autoantibodies and clinical manifestations. Arthritis Rheum (1994) 0.87

Free light chains of immunoglobulins. Scand J Clin Lab Invest Suppl (1981) 0.86

Immunologic events preceding clinical exacerbation of systemic lupus erythematosus. Am J Med (1973) 0.85

Evidence by radioimmunoassay that mitogen-activated human blood mononuclear cells secrete significant amounts of light chain Ig unassociated with heavy chain. Cell Immunol (1986) 0.85

Glomerular filtration rate and urinary albumin excretion rate in systemic lupus erythematosus. Nephron (1995) 0.85

Quantitation of proteinuria in systemic lupus erythematosus by use of a random, spot urine collection. Arthritis Rheum (1983) 0.85

Free light chains in multiple sclerosis and infections of the CNS. Neurology (1987) 0.84

Increased excretion of soluble interleukin 2 receptors and free light chain immunoglobulins in the urine of patients with active lupus nephritis. Ann Rheum Dis (1992) 0.84

Evidence for shared idiotypy expressed by the IgM, IgG, and IgA serum proteins of a patient with a complex multiple paraprotein disorder. J Immunol (1979) 0.84

Stability of alpha 1-microglobulin, beta 2-microglobulin and retinol binding protein in urine. Clin Chim Acta (1989) 0.82

The relationship between soluble interleukin 2 receptor levels and antidouble stranded DNA antibody levels in patients with systemic lupus erythematosus. J Rheumatol (1991) 0.82

Induction of balanced immunoglobulin chain synthesis in free light chain-producing lymphocytes by mitogen stimulation. J Immunol (1981) 0.82

NIH conference. Molecular genetic analysis of human lymphoid neoplasms. Immunoglobulin genes and the c-myc oncogene. Ann Intern Med (1985) 0.81

Increased free light chains in the urine from patients with multiple sclerosis. Neurology (1991) 0.79

Evidence for possible retroviral involvement in autoimmune diseases. Ann Allergy (1992) 0.78

Clinical value of an integrated ELISA system for the detection of 6 autoantibodies (ssDNA, dsDNA, Sm, RNP/Sm, SSA, and SSB). J Rheumatol (1990) 0.78

Restriction of blood and marrow CLL-B cells to free L-chain Ig secretion: implication for normal B-cell function and control. Am J Hematol (1988) 0.77

Validity of retrospective disease activity assessment in systemic lupus erythematosus. J Rheumatol (1996) 0.77

Light chain composition of CSF oligoclonal IgG bands in multiple sclerosis and subacute sclerosing panencephalitis. J Neuroimmunol (1982) 0.76

Identification of the kappa and lambda light chains within the CSF immunoglobulin region in multiple sclerosis and subacute sclerosing panencephalitis by immunofixation after isoelectric focusing. J Neurol (1981) 0.75

Articles by these authors

Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am J Respir Crit Care Med (2001) 2.94

Screening for mental health: validity of the MHI-5 using DSM-IV Axis I psychiatric disorders as gold standard. Psychiatry Res (2001) 2.42

Redesign of PCR primers for mitochondrial cytochrome c oxidase subunit I for marine invertebrates and application in all-taxa biotic surveys. Mol Ecol Resour (2013) 2.27

Factors influencing remission from alcohol dependence without formal help in a representative population sample. Addiction (2001) 2.22

Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J Immunol (1988) 2.19

Volumetric spectroscopic imaging with spiral-based k-space trajectories. Magn Reson Med (1998) 2.05

Cloning of DNA fragments complementary to tobacco nitrate reductase mRNA and encoding epitopes common to the nitrate reductases from higher plants. Mol Gen Genet (1987) 2.05

Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care (2001) 2.02

Expression of the potato tuber ADP-glucose pyrophosphorylase in Escherichia coli. J Biol Chem (1993) 1.83

Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas. EMBO J (1999) 1.73

Primary focal dystonia: evidence for distinct neuropsychiatric and personality profiles. J Neurol Neurosurg Psychiatry (2009) 1.70

Nitrate, a signal relieving seed dormancy in Arabidopsis. Plant Cell Environ (2005) 1.66

Studies on natural recovery from alcohol dependence: sample selection bias by media solicitation? Addiction (2000) 1.65

Early embryonic death of mice deficient in gamma-adaptin. J Biol Chem (1999) 1.64

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Isolation and characterization of Nicotiana plumbaginifolia nitrate reductase-deficient mutants: genetic and biochemical analysis of the NIA complementation group. Mol Gen Genet (1987) 1.56

Development of cytomegalovirus (CMV) disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenemia test. AIDS (1997) 1.53

Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. N Engl J Med (1988) 1.53

Differentiation of polymorphonuclear neutrophils in patients with systemic infections and chronic inflammatory diseases: evidence of prolonged life span and de novo synthesis of fibronectin. J Mol Med (Berl) (2000) 1.47

Direct amplification of plant genomic DNA from leaf and root pieces using PCR. Plant Mol Biol (1991) 1.44

A high yield affinity purification method for specific RNA-binding proteins: isolation of the iron regulatory factor from human placenta. Nucleic Acids Res (1990) 1.43

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

Distinct muscle imaging patterns in myofibrillar myopathies. Neurology (2008) 1.41

Post-transcriptional regulation of nitrate reductase by light is abolished by an N-terminal deletion. Plant Cell (1995) 1.41

Full-length cDNA sequence of a progesterone membrane-binding protein from porcine vascular smooth muscle cells. Biochem Biophys Res Commun (1996) 1.40

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

Nurses vote for the most valuable new drugs. Am J Nurs (1991) 1.39

Maturation and pro-peptide cleavage of beta-secretase. J Biol Chem (2000) 1.38

'End-of-life' care: patients' choices, nurses' challenges. Am J Nurs (1993) 1.38

Feline oncornavirus-associated cell membrane antigen: expression in transformed nonproducer mink cells. Science (1977) 1.37

Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34

Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32

Immunological comparisons of nitrate reductase of different plant species using monoclonal antibodies. Plant Physiol (1986) 1.31

Overexpression in Escherichia coli of the rnf genes from Rhodobacter capsulatus--characterization of two membrane-bound iron-sulfur proteins. Eur J Biochem (1998) 1.30

Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27

Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement. Leukemia (2007) 1.25

Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol. Leukemia (2009) 1.24

Isolation of two Arabidopsis cDNAs involved in early steps of molybdenum cofactor biosynthesis by functional complementation of Escherichia coli mutants. J Biol Chem (1995) 1.20

Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19

Comparative efficacy of oral erythromycin versus oral tetracycline in the treatment of acne vulgaris. A double-blind study. J Am Acad Dermatol (1986) 1.17

Neuropsychiatric lupus. Rheum Dis Clin North Am (1988) 1.17

Background suppression with multiple inversion recovery nulling: applications to projective angiography. Magn Reson Med (1997) 1.15

Association of the ICAM-1Kilifi mutation with protection against severe malaria in Lambaréné, Gabon. Am J Trop Med Hyg (1999) 1.14

Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13

Elimination of mycoplasma from leukemia-lymphoma cell lines using antibiotics. Leukemia (2002) 1.13

Microstructured glass chip for ion-channel electrophysiology. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 1.13

Characterization of an fdxN mutant of Rhodobacter capsulatus indicates that ferredoxin I serves as electron donor to nitrogenase. Biochim Biophys Acta (1995) 1.12

Role of glutamine in human carbohydrate metabolism in kidney and other tissues. Kidney Int (1999) 1.12

Innovative pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: a large observational study under conditions of daily practice. Curr Med Res Opin (2010) 1.10

Anticonvulsant properties of the methanolic extract of Cyperus articulatus (Cyperaceae). J Ethnopharmacol (2001) 1.09

Comparison of survival curves of gastric cancer patients after surgery according to the UICC stage classification and the General Rules for Gastric Cancer Study by the Japanese Research Society for gastric cancer. Ann Surg (1993) 1.09

Interaction of a nuclear location signal with isolated nuclear envelopes and identification of signal-binding proteins by photoaffinity labeling. Proc Natl Acad Sci U S A (1989) 1.09

Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines. Leukemia (1999) 1.08

Gastroesophageal reflux in patients with asthma and chronic bronchitis. Am Rev Respir Dis (1987) 1.08

High-level beta-lactamase activity in sputum samples from cystic fibrosis patients during antipseudomonal treatment. Antimicrob Agents Chemother (1992) 1.07

Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07

Haemophilia A: mutation type determines risk of inhibitor formation. Thromb Haemost (1995) 1.07

Interest in and limits to the utilization of reporter genes for the analysis of transcriptional regulation of nitrate reductase. Mol Gen Genet (1992) 1.06

Human kidney and liver gluconeogenesis: evidence for organ substrate selectivity. Am J Physiol (1998) 1.06

Elective laparoscopic colonic resection for diverticular disease: results of a multicenter study in 179 patients. Surg Endosc (2002) 1.06

1H-cyclopenta[b]benzofuran lignans from Aglaia species inhibit cell proliferation and alter cell cycle distribution in human monocytic leukemia cell lines. Z Naturforsch C (1999) 1.05

A short form of the Fagerström Test for Nicotine Dependence and the Heaviness of Smoking Index in two adult population samples. Addict Behav (2004) 1.05

Monitoring minimal residual disease by quantification of genomic chromosomal breakpoint sequences in acute leukemias with MLL aberrations. Leukemia (2006) 1.05

Associations of perceived work strain with nicotine dependence in a community sample. Occup Environ Med (2006) 1.05

Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05

Laparoscopic antireflux surgery: comparative study of Nissen, Nissen-Rossetti, and Toupet fundoplication. Société Française de Chirurgie Laparoscopique. Surg Endosc (2000) 1.04

Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma. Leukemia (2007) 1.03

Purification of nitrate reductase from Nicotiana plumbaginifolia by affinity chromatography using 5'AMP-sepharose and monoclonal antibodies. Eur J Biochem (1989) 1.03

Impact of multidisciplinary team management in head and neck cancer patients. Br J Cancer (2011) 1.03

Structure activity relationships of antiproliferative rocaglamide derivatives from Aglaia species (Meliaceae). Z Naturforsch C (1999) 1.02

Biliary excretion of ampicillin: experimental and clinical study. Chemotherapy (1977) 1.01

Renal glucose production and utilization: new aspects in humans. Diabetologia (1997) 1.01

Prevalence, quality of life and psychosocial function in obsessive-compulsive disorder and subclinical obsessive-compulsive disorder in northern Germany. Eur Arch Psychiatry Clin Neurosci (2000) 1.01

Combination therapy of pentoxifylline and TNFalpha monoclonal antibody in dextran sulphate-induced mouse colitis. Aliment Pharmacol Ther (1999) 1.01

Alcohol high risk drinking, abuse and dependence among tobacco smoking medical care patients and the general population. Drug Alcohol Depend (2003) 1.01

[Laparoscopic splenectomy for hematologic diseases. Study of 275 cases. French Society of Laparoscopic Surgery]. Ann Chir (2000) 1.01

In vitro and in vivo efficacy of photofrin and pheophorbide a, a bacteriochlorin, in photodynamic therapy of colonic cancer cells. Photochem Photobiol (2002) 1.00

Epitope mapping and affinity purification of monospecific antibodies by Escherichia coli cell surface display of gene-derived random peptide libraries. J Immunol Methods (2001) 1.00

Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99

MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines. Leukemia (2007) 0.99

Transmural gradients of glycolytic enzyme activities in left ventricular myocardium. I. The normal state. Pflugers Arch Gesamte Physiol Menschen Tiere (1967) 0.99

Types of natural recovery from alcohol dependence: a cluster analytic approach. Addiction (2003) 0.99

Effect of progestational agents on gonadal and adrenal cortical function in patients with benign prostatic hypertrophy and carcinoma of the prostate. J Clin Endocrinol Metab (1967) 0.98

Cloning and gene structure of the rod cGMP phosphodiesterase delta subunit gene (PDED) in man and mouse. Eur J Hum Genet (1998) 0.98

Intraoperative blood losses and transfusion requirements during adult liver transplantation remain difficult to predict. Can J Anaesth (2001) 0.97

New insights into the genetic diversity of European porcine reproductive and respiratory syndrome virus (PRRSV). Vet Microbiol (2005) 0.97

Bifunctional reagents for the crosslinking of proteins. Angew Chem Int Ed Engl (1971) 0.96

Biochemical and Immunological Characterization of Nitrate Reductase Deficient nia Mutants of Nicotiana plumbaginifolia. Plant Physiol (1990) 0.96

Optimizing boundary detection via Simulated Search with applications to multi-modal heart segmentation. Med Image Anal (2009) 0.95

[Adverse drug reactions following immunization in Germany pursuant to the German Infection Protection Act and the German Medicinal Products Act from January 1, 2004 to December 31, 2005]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2007) 0.95

Anti-proliferative effects of new staurosporine derivatives isolated from a marine ascidian and its predatory flatworm. Cancer Lett (2001) 0.94

Self-efficacy to refrain from smoking predicted by major depression and nicotine dependence. Addict Behav (2004) 0.94

Cloning, expression, and nucleotide sequence of glgC gene from an allosteric mutant of Escherichia coli B. Arch Biochem Biophys (1992) 0.94